英硅智能：与康哲药业达成药物研发战略合作
CMSCMS(HK:00867) Jin Rong Jie·2026-02-10 00:27

Core Viewpoint - The company, 英硅智能, has announced a strategic collaboration with 康哲药业 for drug development, focusing on AI-powered innovative drug research in the central nervous system and autoimmune diseases [1] Group 1: Collaboration Details - The partnership will leverage 英硅智能's validated AI platform and innovative drug development capabilities alongside 康哲药业's experienced research team and deep understanding of disease areas [1] - The agreement stipulates the joint development of at least two research projects [1] Group 2: Financial Aspects - 英硅智能 is expected to receive up to several tens of millions of Hong Kong dollars in research funding for each project [1]